Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease
Jay Shah1,2,3, Toluwalase Okubote1,2,3, Naim Alkhouri1,2,3
1Dr Shah is an assistant professor of pediatrics at the University of Texas Health San Antonio in San Antonio, Texas.
Insights
Pediatric nonalcoholic fatty liver disease (NAFLD) is increasingly common, driven by genetics, insulin resistance, and obesity. Recent guidelines offer updated strategies for diagnosing and managing this growing childhood liver condition.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Metabolic Disorders
Background:
- Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive liver fat accumulation without significant alcohol use.
- In children, NAFLD is linked to genetic factors, insulin resistance, and obesity.
- Pediatric NAFLD is the most prevalent chronic liver disease in children, with a rising incidence over recent decades.
Purpose of the Study:
- To provide an overview of the burden and natural history of pediatric NAFLD.
- To focus on the diagnosis and management of pediatric NAFLD.
- To incorporate insights from recently updated clinical guidelines.
Main Methods:
- Review of current literature on pediatric NAFLD.
- Analysis of recent guideline publications from major hepatology and gastroenterology societies.
- Synthesis of information on disease prevalence, etiology, diagnosis, and management.
Main Results:
- NAFLD is the most common chronic liver disease in children, with increasing prevalence.
- Diagnosis and management present challenges due to rising disease rates.
- Updated guidelines from North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (2017) and American Association for the Study of Liver Diseases offer new management strategies.
Conclusions:
- Pediatric NAFLD represents a significant public health challenge.
- Adherence to updated diagnostic and management guidelines is crucial for addressing the growing burden of childhood NAFLD.
- Further research into the long-term outcomes and effective interventions for pediatric NAFLD is warranted.
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is a form of chronic liver disease that is characterized by excessive fatty infiltration of the liver in the absence of significant alcohol consumption. As in the adult population, the etiology of NAFLD in children has been attributed to genetic predilection, insulin resistance, and obesity. The prevalence of NAFLD in the pediatric population has consistently increased over the past few decades, and it is currently considered the most common chronic liver disease in children. With increasing disease prevalence, NAFLD diagnosis and management have become more challenging. New guidelines for the management of pediatric NAFLD were published in 2017 by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Additionally, the American Association for the Study of Liver Diseases updated their guidelines on NAFLD and included a section dedicated to the pediatric population. This article provides an overall description of the burden and natural history of pediatric NAFLD, with a focus on diagnosis and management in light of the recently updated guidelines.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
Related Concept Videos
01:28Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:15Parkinson's Disease: Overview
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...